湖(hu)(hu)北亨(heng)(heng)(heng)迪(di)(di)藥(yao)(yao)業(ye)(ye)股(gu)份(fen)有(you)(you)(you)限公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)于(yu)2020年6月28日(ri)由(you)湖(hu)(hu)北百(bai)科(ke)(ke)亨(heng)(heng)(heng)迪(di)(di)藥(yao)(yao)業(ye)(ye)有(you)(you)(you)限公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)改制更名(ming)而(er)來(lai),現(xian)有(you)(you)(you)員(yuan)工(gong)900多人。主(zhu)要從事醫(yi)(yi)藥(yao)(yao)原料藥(yao)(yao)和制劑(ji)產(chan)(chan)品的研發(fa)、生(sheng)產(chan)(chan)和銷售(shou)。注(zhu)冊地(di)和生(sheng)產(chan)(chan)基(ji)地(di)設(she)于(yu)湖(hu)(hu)北荊門,研發(fa)和銷售(shou)中心(xin)設(she)于(yu)武(wu)漢(han)(han)。公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)下(xia)設(she)3個(ge)子公(gong)(gong)(gong)(gong)司(si)(si)(si)(si):武(wu)漢(han)(han)百(bai)科(ke)(ke)藥(yao)(yao)物(wu)開發(fa)有(you)(you)(you)限公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)、武(wu)漢(han)(han)亨(heng)(heng)(heng)迪(di)(di)藥(yao)(yao)物(wu)開發(fa)有(you)(you)(you)限公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)、湖(hu)(hu)北百(bai)科(ke)(ke)醫(yi)(yi)藥(yao)(yao)商貿有(you)(you)(you)限公(gong)(gong)(gong)(gong)司(si)(si)(si)(si),1個(ge)分(fen)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si):湖(hu)(hu)北亨(heng)(heng)(heng)迪(di)(di)藥(yao)(yao)業(ye)(ye)股(gu)份(fen)有(you)(you)(you)限公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)研究院分(fen)公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)。公(gong)(gong)(gong)(gong)司(si)(si)(si)(si)是湖(hu)(hu)北省高新(xin)技(ji)術企業(ye)(ye)、湖(hu)(hu)北省博士后創新(xin)實踐(jian)基(ji)地(di)、華中科(ke)(ke)技(ji)大學(xue)(xue)同(tong)濟醫(yi)(yi)學(xue)(xue)院藥(yao)(yao)學(xue)(xue)教學(xue)(xue)基(ji)地(di)、湖(hu)(hu)北省2020年新(xin)冠(guan)肺炎(yan)抗(kang)疫6家知名(ming)保供企業(ye)(ye)之一。
公司是全球六大主要(yao)布洛(luo)芬原料藥(yao)(yao)生產(chan)(chan)企業之一、國(guo)內(nei)重要(yao)的解(jie)熱鎮痛原料藥(yao)(yao)基地、湖北省抗(kang)腫(zhong)瘤特(te)色原料藥(yao)(yao)基地和(he)固體(ti)制(zhi)劑制(zhi)造基地,擁有50多(duo)(duo)個(ge)醫(yi)藥(yao)(yao)原料藥(yao)(yao)和(he)制(zhi)劑品規(gui),其中解(jie)熱鎮痛原料藥(yao)(yao)布洛(luo)芬年產(chan)(chan)能(neng)3500噸(dun)(dun),產(chan)(chan)品客戶遍及全世界80多(duo)(duo)個(ge)國(guo)家和(he)地區;右旋(xuan)布洛(luo)芬年產(chan)(chan)能(neng)200噸(dun)(dun),托拉塞米年產(chan)(chan)能(neng)10噸(dun)(dun),醋(cu)酸阿比特(te)龍(long)年產(chan)(chan)能(neng)4噸(dun)(dun),以及多(duo)(duo)個(ge)CDMO車間;固體(ti)制(zhi)劑年產(chan)(chan)能(neng)10億片(pian)片(pian)劑、3億粒(li)膠囊、1億袋(dai)顆粒(li)劑。
公(gong)司目前共有十(shi)幾個品種在歐(ou)美(mei)進行(xing)了注冊,荊門(men)和武漢兩個基(ji)地共十(shi)一次通(tong)過歐(ou)美(mei)藥監(jian)局(ju)檢查(cha)認證,是國內同時通(tong)過歐(ou)美(mei)GMP認證檢查(cha)的(de)為數不(bu)多企業之一。
公(gong)司(si)堅持原料藥為主,做(zuo)精做(zuo)強,將公(gong)司(si)打造和(he)(he)建設(she)成為國(guo)內重(zhong)要的非(fei)甾(zai)體抗炎類原料藥和(he)(he)特色(se)原料藥生產基地,將進(jin)一步發力布局原料藥CDMO和(he)(he)制劑業務,實現(xian)原料藥與制劑兩(liang)個(ge)板塊(kuai)協同(tong)發展。